AKEP Stock Overview Manufactures and sells specialty chemicals and advanced materials worldwide. More details
Rewards Risk Analysis No risks detected for AKEP from our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
Price History & Performance
Summary of share price highs, lows and changes for Arkema Historical stock prices Current Share Price €74.90 52 Week High €99.50 52 Week Low €69.70 Beta 1.15 1 Month Change 6.62% 3 Month Change -10.14% 1 Year Change n/a 3 Year Change -40.34% 5 Year Change -10.81% Change since IPO 11.24%
Recent News & Updates
Arkema S.A. (ENXTPA : AKE) completed the acquisition of Flexible packaging laminating adhesives business of The Dow Chemical Company for $150 million. Dec 03 Arkema S.A. to Report First Half, 2025 Results on Jul 31, 2025
Arkema S.A. to Report Q1, 2025 Results on May 07, 2025 Nov 06
Arkema Launches Ethyl Acrylate Based Entirely on Bioethanol Oct 11
Arkema S.A. Announces Management Changes Aug 29
Arkema S.A. to Report Fiscal Year 2024 Results on Feb 27, 2025 Aug 01 See more updates
Arkema S.A. (ENXTPA : AKE) completed the acquisition of Flexible packaging laminating adhesives business of The Dow Chemical Company for $150 million. Dec 03 Arkema S.A. to Report First Half, 2025 Results on Jul 31, 2025
Arkema S.A. to Report Q1, 2025 Results on May 07, 2025 Nov 06
Arkema Launches Ethyl Acrylate Based Entirely on Bioethanol Oct 11
Arkema S.A. Announces Management Changes Aug 29
Arkema S.A. to Report Fiscal Year 2024 Results on Feb 27, 2025 Aug 01
Dividend increased to €3.50 May 16 Arkema S.A. (ENXTPA:AKE) agreed to acquire The Dow Chemical Company from Dow Inc. (NYSE:DOW) for an enterprise value of $150 million. May 03
Dividend increased to €3.50 Apr 27
Dividend increased to €3.50 Mar 08
Full year 2023 earnings released: EPS: €5.39 (vs €12.81 in FY 2022) Mar 02 Arkema S.A. to Report Q2, 2024 Results on Aug 01, 2024
Arkema S.A. (ENXTPA:AKE) acquired an unknown minority stake in Tiamat. Jan 12
Arkema S.A. (ENXTPA:AKE) acquired Arc Bulding Products. Dec 14
Arkema S.A. (ENXTPA:AKE) completed the acquisition of 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity. Dec 02
Third quarter 2023 earnings released: EPS: €1.39 (vs €2.88 in 3Q 2022) Nov 10
Arkema S.A. to Report Q1, 2024 Results on May 07, 2024 Nov 10
Arkema S.A., Annual General Meeting, May 15, 2024 Nov 09
Second quarter 2023 earnings released: EPS: €1.96 (vs €5.35 in 2Q 2022) Aug 01 Arkema S.A. (ENXTPA:AKE) agreed to acquire a 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity for approximately €730 million. Jun 30
Arkema S.A. (ENXTPA:AKE) agreed to acquire a 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity for approximately €730 million. Jun 29
Arkema S.A. agreed to acquire Polytec PT GmbH Polymere Technologien. May 18
Arkema S.A. Appoints Florence Lambert and Séverin Cabannes as Director May 12
Upcoming dividend of €3.40 per share at 3.9% yield May 08
First quarter 2023 earnings released: EPS: €1.70 (vs €4.34 in 1Q 2022) May 06
Full year 2022 earnings released: EPS: €12.81 (vs €17.15 in FY 2021) Apr 01
Full year 2022 earnings released: EPS: €12.81 (vs €17.15 in FY 2021) Feb 24
Arkema S.A. Announces Executive Changes Feb 16
Prayon S.A. completed the acquisition of Febex S.A from Arkema S.A. (ENXTPA:AKE). Jan 04 Arkema S.A. to Report Q1, 2023 Results on May 05, 2023
Third quarter 2022 earnings released: EPS: €2.88 (vs €3.19 in 3Q 2021) Nov 16
Prayon S.A. entered into an agreement to acquire Febex S.A from Arkema S.A. (ENXTPA:AKE). Oct 29 Arkema S.A. (ENXTPA:AKE) acquired Polimeros Especiales, S.A. De C.V. Sep 02
Second quarter 2022 earnings released Jul 30 Arkema S.A. to Report Fiscal Year 2022 Results on Feb 23, 2023 Jul 29
Arkema S.A. (ENXTPA:AKE) agreed to acquire Polimeros Especiales, S.A. De C.V. Jul 22
Investor sentiment deteriorated over the past week Jun 16
Upcoming dividend of €3.00 per share May 16
First quarter 2022 earnings released: EPS: €4.34 (vs €1.62 in 1Q 2021) May 06
Full year 2021 earnings released: EPS: €17.13 (vs €3.98 in FY 2020) Mar 31
Investor sentiment deteriorated over the past week Mar 05
Arkema S.A. (ENXTPA:AKE) completed the acquisition of Performance Adhesives Business of Ashland LLC. Mar 02
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Feb 25 Arkema S.A. to Report Q3, 2022 Results on Nov 10, 2022
Arkema S.A. Recommends Dividend, Payable on May 25, 2022 Feb 24
Arkema S.A. (ENXTPA:AKE) agreed to acquire Shanghai Zhiguan Polymer Materials. Feb 22
Arkema S.A. (ENXTPA:AKE) agreed to acquire Permoseal (Pty) Ltd. Dec 17
Third quarter 2021 earnings released: EPS €3.19 (vs €1.02 in 3Q 2020) Nov 11
Cargill, Incorporated agreed to acquire Epoxides Business of Arkema S.A. (ENXTPA:AKE) for $38.8 million. Sep 29
Arkema S.A. (ENXTPA:AKE) entered into a Purchase and Sale Agreement to acquire Performance Adhesives Business of Ashland LLC for $1.7 billion. Sep 01
Second quarter 2021 earnings released: EPS €10.82 (vs €1.56 in 2Q 2020) Jul 30
Arkema Announces New Breakthrough Range of Renewable PVDF Grades for Lithium-Ion Batteries Jun 18
Arkema S.A. (ENXTPA:AKE) agreed to acquire Erpro 3d Factory. Jun 09
Non-Executive Independent Director has left the company May 26
Non-Executive Independent Director has left the company May 26
Non-Executive Independent Director has left the company May 26
Upcoming dividend of €2.50 per share May 19
First quarter 2021 earnings released: EPS €1.56 (vs €1.02 in 1Q 2020) May 07
Trinseo S.A. (NYSE:TSE) completed the acquisition of polymethyl methacrylates and activated methyl methacrylates business from Arkema S.A. (ENXTPA:AKE). May 05
Full year 2020 earnings released: EPS €3.98 (vs €6.45 in FY 2019) Mar 28
New 90-day high: €98.57 Mar 09
Full year 2020 earnings released: EPS €4.34 (vs €6.45 in FY 2019) Feb 26
Revenue beats expectations Feb 26
New 90-day low: €88.79 Feb 07 Arkema S.A. to Report First Half, 2021 Results on Jul 29, 2021
Trinseo S.A. (NYSE:TSE) entered into a binding agreement to acquire polymethyl methacrylates and activated methyl methacrylates business from Arkema S.A. (ENXTPA:AKE) for an enterprise value of approximately $1.4 billion. Dec 15
Arkema S.A. to Report Fiscal Year 2020 Results on Feb 25, 2021 Jul 31 Shareholder Returns AKEP GB Chemicals GB Market 7D 4.5% 3.7% 3.3% 1Y n/a -17.7% 10.6%
See full shareholder returns
Return vs Market: Insufficient data to determine how AKEP performed against the UK Market .
Price Volatility Is AKEP's price volatile compared to industry and market? AKEP volatility AKEP Average Weekly Movement 4.3% Chemicals Industry Average Movement 5.9% Market Average Movement 4.9% 10% most volatile stocks in GB Market 10.8% 10% least volatile stocks in GB Market 2.6%
Stable Share Price: AKEP has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine AKEP's volatility change over the past year.
About the Company Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Show more Arkema S.A. Fundamentals Summary How do Arkema's earnings and revenue compare to its market cap? AKEP fundamental statistics Market cap €5.66b Earnings (TTM ) €346.00m Revenue (TTM ) €9.49b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) AKEP income statement (TTM ) Revenue €9.49b Cost of Revenue €7.55b Gross Profit €1.94b Other Expenses €1.60b Earnings €346.00m
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 27, 2025
Earnings per share (EPS) 4.58 Gross Margin 20.45% Net Profit Margin 3.64% Debt/Equity Ratio 59.1%
How did AKEP perform over the long term?
See historical performance and comparison Dividends
4.7% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/20 08:49 End of Day Share Price 2025/01/17 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Arkema S.A. is covered by 37 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Martin Schnee AlphaValue Andreas Heine Barclays James Stewart Barclays
Show 34 more analysts 
